These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37822297)

  • 1. Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy.
    Geuens S; Van Dessel J; Govaarts R; Ikelaar NA; Meijer OC; Kan HE; Niks EH; Goemans N; Lemiere J; Doorenweerd N; De Waele L
    Ann Clin Transl Neurol; 2023 Dec; 10(12):2324-2333. PubMed ID: 37822297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids for the treatment of Duchenne muscular dystrophy.
    Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
    Guglieri M; Bushby K; McDermott MP; Hart KA; Tawil R; Martens WB; Herr BE; McColl E; Speed C; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Willis T; Griggs RC; ; Straub V; van Ruiten H; Childs AM; Ciafaloni E; Shieh PB; Spinty S; Maggi L; Baranello G; Butterfield RJ; Horrocks IA; Roper H; Alhaswani Z; Flanigan KM; Kuntz NL; Manzur A; Darras BT; Kang PB; Morrison L; Krzesniak-Swinarska M; Mah JK; Mongini TE; Ricci F; von der Hagen M; Finkel RS; O'Reardon K; Wicklund M; Kumar A; McDonald CM; Han JJ; Joyce N; Henricson EK; Schara-Schmidt U; Gangfuss A; Wilichowski E; Barohn RJ; Statland JM; Campbell C; Vita G; Vita GL; Howard JF; Hughes I; McMillan HJ; Pegoraro E; Bello L; Burnette WB; Thangarajh M; Chang T
    JAMA; 2022 Apr; 327(15):1456-1468. PubMed ID: 35381069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
    Smith EC; Conklin LS; Hoffman EP; Clemens PR; Mah JK; Finkel RS; Guglieri M; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; Kerchner L; Morgenroth LP; Arrieta A; Shimony M; Jaros M; Shale P; Gordish-Dressman H; Hagerty L; Dang UJ; Damsker JM; Schwartz BD; Mengle-Gaw LJ; McDonald CM;
    PLoS Med; 2020 Sep; 17(9):e1003222. PubMed ID: 32956407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy.
    Lit L; Sharp FR; Apperson M; Liu DZ; Walker WL; Liao I; Xu H; Ander BP; Wong B
    Pharmacogenomics J; 2009 Dec; 9(6):411-8. PubMed ID: 19488064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.
    Doorenweerd N; Straathof CS; Dumas EM; Spitali P; Ginjaar IB; Wokke BH; Schrans DG; van den Bergen JC; van Zwet EW; Webb A; van Buchem MA; Verschuuren JJ; Hendriksen JG; Niks EH; Kan HE
    Ann Neurol; 2014 Sep; 76(3):403-11. PubMed ID: 25043804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status.
    McDonald CM; Marden JR; Shieh PB; Wong BL; Lane H; Zhang A; Nguyen H; Frean M; Trifillis P; Koladicz K; Signorovitch J
    J Comp Eff Res; 2023 Apr; 12(4):e220190. PubMed ID: 36749302
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.
    Koeks Z; Bladen CL; Salgado D; van Zwet E; Pogoryelova O; McMacken G; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Bellgard MI; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lähdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Herczegfalvi A; Viswanathan V; Bayat F; Buccella F; Ferlini A; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Klein A; Díaz-Manera J; Gallardo E; Karaduman AA; Oznur T; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Kirschner J; Flanigan KM; Straub V; Bushby K; Béroud C; Verschuuren JJ; Lochmüller H
    J Neuromuscul Dis; 2017; 4(4):293-306. PubMed ID: 29125504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up.
    Merlini L; Gennari M; Malaspina E; Cecconi I; Armaroli A; Gnudi S; Talim B; Ferlini A; Cicognani A; Franzoni E
    Muscle Nerve; 2012 Jun; 45(6):796-802. PubMed ID: 22581531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.
    Guglieri M; Bushby K; McDermott MP; Hart KA; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Willis T; Hirtz D; Shieh PB; Straub V; Childs AM; Ciafaloni E; Butterfield RJ; Horrocks I; Spinty S; Flanigan KM; Kuntz NL; Baranello G; Roper H; Morrison L; Mah JK; Manzur AY; McDonald CM; Schara U; von der Hagen M; Barohn RJ; Campbell C; Darras BT; Finkel RS; Vita G; Hughes I; Mongini T; Pegoraro E; Wicklund M; Wilichowski E; Bryan Burnette W; Howard JF; McMillan HJ; Thangarajh M; Griggs RC
    Contemp Clin Trials; 2017 Jul; 58():34-39. PubMed ID: 28450193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids in Duchenne muscular dystrophy: major variations in practice.
    Griggs RC; Herr BE; Reha A; Elfring G; Atkinson L; Cwik V; McColl E; Tawil R; Pandya S; McDermott MP; Bushby K
    Muscle Nerve; 2013 Jul; 48(1):27-31. PubMed ID: 23483575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting-state functional MRI shows altered default-mode network functional connectivity in Duchenne muscular dystrophy patients.
    Doorenweerd N; de Rover M; Marini-Bettolo C; Hollingsworth KG; Niks EH; Hendriksen JGM; Kan HE; Straub V
    Brain Imaging Behav; 2021 Oct; 15(5):2297-2307. PubMed ID: 33389442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
    Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of muscle weakness in Duchenne muscular dystrophy.
    Rivera SR; Jhamb SK; Abdel-Hamid HZ; Acsadi G; Brandsema J; Ciafaloni E; Darras BT; Iannaccone ST; Konersman CG; Kuntz NL; McDonald CM; Parsons JA; Tesi Rocha C; Zaidman CM; Butterfield RJ; Connolly AM; Mathews KD
    PLoS One; 2020; 15(10):e0240687. PubMed ID: 33075081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone and deflazacort in Duchenne muscular dystrophy: a patient perspective and plain language summary publication of the Cincinnati study.
    Wong BL; Cook T; Miller H
    J Comp Eff Res; 2022 Aug; 11(11):779-786. PubMed ID: 35713895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.
    Liang WC; Wang CH; Chou PC; Chen WZ; Jong YJ
    Pediatr Neonatol; 2018 Apr; 59(2):176-183. PubMed ID: 28903883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.
    Preethish-Kumar V; Shah A; Kumar M; Ingalhalikar M; Polavarapu K; Afsar M; Rajeswaran J; Vengalil S; Nashi S; Thomas PT; Sadasivan A; Warrier M; Nalini A; Saini J
    AJNR Am J Neuroradiol; 2020 Jul; 41(7):1271-1278. PubMed ID: 32616576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.